• English
  • Italiano
HEAL ITALIA
  • Foundation
    • Governing and advisory bodies
    • Unit for European Strategic Intelligence
    • Partner
  • HEAL Italia Project
    • Heal Italia Roadshow
    • Providentia Campaign
    • HEAL Italia Forum 2026
    • Thematic Networks
      • Holistic and Omics Nosology
      • Smart Health and Data
      • Predictive Models
      • Precision Diagnostics
      • Next-Generation Therapies
      • Medical Devices and Technologies
      • Personalized Prevention
      • Clinical Trials
  • Publication
  • Services
    • HEAL Italia Academy
    • Internazionalization
      • Heal Italia abroad
    • Technology Transfer
  • Notices
    • Cascade Call Projects
    • Cascade Calls
    • HUB Calls
  • Core Facilities
    • The HEAL Italia Biobank Network and the Collaboration with BBMRI
  • News
    • Press review

Cerca nel sito

Home » Research » Page 7

Research

Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes
2025 Spoke 3 Rare diseases and genetic disorders

Valentina Sangiorgio, Federica Mottadelli, Fabio Pagni, Fabrizio Cavalca, Giovanni Cazzaniga, Martina Venegoni, Carlo Gambacorti-Passerini, Rocco Piazza, Elena Maria Elli

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models
2025 Spoke 3 Oncology and innovative therapies

Alessia Anastasia, Laura Formenti, Paola Ostano, Lucia Minoli, Andrea Resovi, Lavinia Morosi, Claudia Fioravanti, Edoardo Micotti, Cristina Matteo, Eugenio Scanziani, Giovanna Chiorino, Raffaella Giavazzi, Carmen Ghilardi, Dorina Belotti

Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments
2024 Spoke 3 Gender medicine Oncology and innovative therapies

Paolo Castorina, Filippo Castiglione, Gianluca Ferini, Stefano Forte, Emanuele Martorana, Dario Giuffrida, Filippo Castiglione

Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?
2024 Spoke 3 Oncology and innovative therapies

Giulia Miglietta, Marco Russo, Giovanni Capranico & Jessica Marinello

CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
2025 Spoke 3 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Alina Catalina Palcau, Claudio Pulito, Valentina De Pascale, Luca Casadei, Mariacristina Valerio, Andrea Sacconi, Valeria Canu, Daniela Rutigliano, Sara Donzelli, Federica Lo Sardo, Francesca Romana Auciello, Fulvia Pimpinelli, Paola Muti, Claudio Botti, Sabrina Strano, Giovanni Blandino

Clinical Applications of Artificial Intelligence in Teleorthodontics: A Scoping Review
2025 Spoke 2 Gender medicine

Alessandro Polizzi, Sara Serra, Rosalia Leonardi , Gaetano Isola

Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
2025 Spoke 3 Oncology and innovative therapies

Francesco Verona , Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi

Atrial natriuretic peptide (ANP) modulates stress-induced autophagy in endothelial cells
2025 Spoke 1 Cardiovascular diseases Preclinical studies on fundamental disease mechanisms

Maurizio Forte, Simona Marchitti, Flavio di Nonno, Donatella Pietrangelo, Rosita Stanzione, Maria Cotugno, Luca D’Ambrosio, Alessandra D’Amico, Vittoria Cammisotto, Gianmarco Sarto, Erica Rocco, Beatrice Simeone, Sonia Schiavon, Daniele Vecchio, Roberto Carnevale, Salvatore Raffa, Giacomo Frati, Massimo Volpe, Sebastiano Sciarretta, Speranza Rubattu

The Role of Transglutaminase 2 in Cancer: An Update
2024 Spoke 1 Oncology and innovative therapies

Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, Alberta Palazzo, Valentina Brillo, Ilaria Celotti, Matteo Scavezzon, Federica Rossin, Luigi Leanza, Filippo Severin

Decreased circulating IPA levels identify subjects with metabolic comorbidities: A multi-omics study
2024 Spoke 1 Metabolic diseases and systemic inflammation Preclinical studies on fundamental disease mechanisms

Marta Ballanti, Lorenzo Antonetti, Maria Mavilio, Viviana Casagrande, Alessandro Moscatelli, Daniele Pietrucci, Adelaide Teofani , Chiara Internò, Marina Cardellini, Omero Paoluzi, Giovanni Monteleone, Philippe Lefebvre, Bart Staels, Geltrude Mingrone, Rossella Menghini, Massimo Federici

Chapter Four – Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis
2023 Spoke 1 Oncology and innovative therapies

Giulia Gallerani, Tania Rossi, Manuela Ferracin, Massimiliano Bonafè

CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma
2024 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Lorenzo Cuollo, Samuele Di Cristofano, Annamaria Sandomenico, Emanuela Iaccarino, Angela Oliver, Alessandra Zingoni, Marco Cippitelli, Cinzia Fionda, Sara Petillo, Andrea Kosta, Valentina Tassinari, Maria Teresa Petrucci, Francesca Fazio, Menotti Ruvo, Angela Santoni, Domenico Raimondo, Alessandra Soriani

Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts
2024 Spoke 1 Oncology and innovative therapies

Lara Tavernari, Sebastiano Rontauroli, Ruggiero Norfo, Margherita Mirabile, Monica Maccaferri, Barbara Mora, Elena Genovese, Sandra Parenti, Chiara Carretta, Elisa Bianchi, Matteo Bertesi, Francesca Pedrazzi, Elena Tenedini, Silvia Martinelli, Maria Teresa Bochicchio, Paola Guglielmelli, Leonardo Potenza, Alessandro Lucchesi, Francesco Passamonti, Enrico Tagliafico, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini

Association between Controlling Nutritional Status (CONUT) Score and Body Composition, Inflammation and Frailty in Hospitalized Elderly Patients
2024 Spoke 1 Metabolic diseases and systemic inflammation

Aurelio Lo Buglio, Francesco Bellanti, Daniela Francesca Pia Carmignano, Gaetano Serviddio and Gianluigi Vendemiale

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
2024 Spoke 1 Neurodegenerative diseases Preclinical studies on fundamental disease mechanisms

Hina Kanwal, Moris Sangineto, Martina Ciarnelli, Pasqualina Castaldo, Rosanna Villani, Antonino Davide Romano, Gaetano Serviddio and Tommaso Cassano

Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis
2024 Spoke 1 Metabolic diseases and systemic inflammation Preclinical studies on fundamental disease mechanisms

Moris Sangineto, Martina Ciarnelli, Tommaso Colangelo, Archana Moola, Vidyasagar Naik Bukke, Loren Duda, Rosanna Villani, Antonino Romano, Stefania Giandomenico, Hina Kanwal, Gaetano Serviddio

The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism
2024 Spoke 1 Infectious diseases and Immunology

Giuseppe Pannone, Maria Carmela Pedicillo, Ilenia Sara De Stefano, Francesco Angelillis, Raffaele Barile, Chiara Pannone, Giuliana Villani, Francesco Miele,Maurizio Municinò, Andrea Ronchi, Gaetano Serviddio, Federica Zito Marino, Renato Franco, Tommaso Colangelo and Rosanna Zamparese

Large-scale DNA sequencing identifies rare variants associated with Systemic Lupus Erythematosus susceptibility in known risk genes
2024 Spoke 1 Rare diseases and genetic disorders

Andrea Latini, Paola Borgiani, Giada De Benedittis, Cinzia Ciccacci, Lucia Novelli, Gerardo Pepe, Manuela Helmer-Citterich, Isabella Baldini, Carlo Perricone, Fulvia Ceccarelli, Fabrizio Conti, Generoso Ianniciello, Juan Caceres, Riccardo Ottalevi, Mattia Capulli, Giuseppe Novelli

Mitophagy modulation for the treatment of cardiovascular diseases
2024 Spoke 1 Cardiovascular diseases Preclinical studies on fundamental disease mechanisms

Maurizio Forte, Luca D’Ambrosio, Gabriele G. Schiattarella, Nadia Salerno, Marco Alfonso Perrone, Francesco S. Loffredo, Edoardo Bertero, Kalliopi Pilichou, Girolamo Manno, Valentina Valenti, Luigi Spadafora, Marco Bernardi, Beatrice Simeone, Gianmarco Sarto, Giacomo Frati, Cinzia Perrino, Sebastiano Sciarretta, the Italian Society of Cardiology Working Group on Cellular and Molecular Biology of the Heart

Sex differences in chronic kidney disease–related complications and mortality across levels of glomerular filtration rate
2024 Spoke 1 Gender medicine

Gianmarco Lombardi , Pietro Manuel Ferraro , Elisa De Tomi , Matteo Bargagli , Andrea Spasiano , Giovanni Gambaro

The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors
2024 Spoke 1 Metabolic diseases and systemic inflammation Rare diseases and genetic disorders

Andrea Latini, Giada De Benedittis, Paola Conigliaro, Chiara Bonini, Chiara Morgante, Maria Iacovantuono, Arianna D’Antonio, Alberto Bergamini, Giuseppe Novelli, Maria Sole Chimenti, Cinzia Ciccacci and Paola Borgiani

Metastatic outgrowth via the two-way interplay of autophagy and metabolism
2023 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Amir Barzegar Behrooz, Marco Cordani, Massimo Donadelli, Saeid Ghavami

A Novel Prognostic Biomarker in Metastatic Prostate Cancer
2023 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Manuela Montanaro, Massimiliano Agostini, Lucia Anemona, Elena Bonanno, Francesca Servadei, Enrico Finazzi Agrò, Anastasios D. Asimakopoulos, Carlo Ganini, Chiara Cipriani, Marta Signoretti, Pierluigi Bove, Francesco Rugolo, ,Benedetta Imperiali, Gerry Melino , Alessandro Mauriello andManuel Scimeca

Gene expression in organoids: an expanding horizon
2023 Spoke 1 Rare diseases and genetic disorders Preclinical studies on fundamental disease mechanisms

Artem Smirnov, Gerry Melino & Eleonora Candi

The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
2024 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Amir Barzegar Behrooz, Marco Cordani, Alessandra Fiore, Massimo Donadelli e Joseph W. Gordon, Daniel J. Klionsky, Saeid Ghavami

Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy
2024 Spoke 1 Advanced diagnostics

Giada De Benedittis, Arianna D’Antonio, Andrea Latini, Chiara Morgante, Paola Conigliaro, Paola Triggianese, Alberto Bergamini, Giuseppe Novelli, Cinzia Ciccacci, Maria Sole Chimenti, Paola Borgiani

Transglutaminase 2 and Ferroptosis: a new liaison?
2023 Spoke 1 Preclinical studies on fundamental disease mechanisms

Mara Gagliardi, Valentina Saverio, Federica Rossin, Manuela D’Eletto & Marco Corazzari

Serine and one-carbon metabolism sustain non-melanoma skin cancer progression
2023 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Angela Cappello, Alessandro Zuccotti, Mara Mancini, Giulia Tosetti, Luca Fania, Francesco Ricci, Gerry Melino & Eleonora Candi

Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells

Luca Occhigrossi, Manuela D’Eletto, Alessio Vecchio, Mauro Piacentini & Federica Rossin

B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling

Erica Foffi, Francesco Rugolo, Nisha Ramamurthy and Tak W. Mak

Ejaculatory abstinence duration impacts semen parameters: Insights from a retrospective analysis in male infertility on 23,527 analyses
2025 Spoke 4 Gender medicine

Giorgio Ivan Russo, Maria Giovanna Asmundo, Andrea Cocci, Ali Saber Abdelhameed, Annalisa Liprino, Filippo Giacone, Debora Lombardo, Antonino Guglielmino,
Sandrine Chamayou

Deep Learning Approaches for Morphological Classification of Intestinal Organoids
2025 Spoke 3 Advanced diagnostics

Giovanni Cicceri, Sebastiano Di Bella, Simone Di Franco, Giorgio Stassi, Matilde Todaro, Salvatore Vitabile

Genomic context influences translesion synthesis DNA polymerase-dependent mechanisms of micronuclei induction by G-quadruplexes
2025 Spoke 3 Oncology and innovative therapies

Simona Pepe, Federico Guerra, Marco Russo, Renée, Duardo, Giovanni Capranico

DDGemb: predicting protein stability change upon single- and multi-point variations with embeddings and deep learning
2025 Spoke 3 Advanced diagnostics

Castrense Savojardo , Matteo Manfredi , Pier Luigi Martelli , Rita Casadio

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
2025 Spoke 3 Oncology and innovative therapies

Michele Massimino, Elena Tirrò,Stefania Stella, Cristina Tomarchio, Sebastiano Di Bella,Silvia Rita Vitale, Chiara Conti, Marialuisa Puglisi, Rosa Maria Di Crescenzo, Silvia Varricchio, Francesco Merolla, Giuseppe Broggi, Federica Martorana, Alice Turdo, Miriam Gaggianesi, Livia Manzella, Andrea Russo, Giorgio Stassi, Rosario Caltabiano, Stefania Staibano

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies
2024 Spoke 3 Preclinical studies on fundamental disease mechanisms

Federica Malighetti, Matteo Villa, Mario Mauri, Simone Piane, Valentina Crippa, Ilaria Crespiatico, Federica Cocito, Elisa Bossi, Carolina Steidl, Ivan Civettini, Chiara Scollo, Daniele Ramazzotti, Carlo Gambacorti-Passerini, Rocco Piazza, Luca Mologni and Andrea Aroldi

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
2024 Spoke 3 Rare diseases and genetic disorders

Francesco Saettini, Fabiola Guerra, Mario Mauri, Claire G. Salter, Margaret P. Adam, David Adams, Emma L. Baple, Estibaliz Barredo, Sanil Bhatia, Arndt Borkhardt, Alfredo Brusco, Cristina Bugarin, Clizia Chinello, Andrew H. Crosby, Precilla D’Souza, Vanna Denti, Grazia Fazio, Silvia Giuliani, Hye Sun Kuehn, Hassan Amel, Asha Elmi, Bernice Lo, Federica Malighetti, Giorgia Mandrile, Andrea Martín-Nalda, Heather C. Mefford, Daniele Moratto, Fatemeh Emam Mousavi, Zoe Nelson, Luis González Gutiérrez-Solana, Ellen Macnamara, Vincent Michaud, Melanie O’Leary, Lisa Pagani, Lisa Pavinato, Patricia VVelez Santamaria, Laura Planas-Serra, Manuel Quadri, Miquel Raspall-Chaure, Stefano Rebellato, Sergio D. Rosenzweig, Agathe Roubertie, Dirk Holzinger, Christin Deal, Catherine Walsh Vockley, Angela Maria Savino, Jennifer L.Stoddard, Holm H. Uhlig, Aurora Pujol, Fulvio Magni, Giuseppe Paglia, Gianni Cazzaniga, Rocco Piazza, Matteo Barberis & Andrea Biondi

BEAT – An Agile Design Framework for Telemedicine in Hypertension
2025 Spoke 2 Advanced diagnostics Advanced technologies and experimental models

Matteo Mantovani; Denise Cosolo; Francesco Pio Anzillotti; Cristiano Fava; Pietro Minuz; Carlo Combi

Assessing Artificial Intelligence in Oral Cancer Diagnosis: A Systematic Review
2024 Spoke 2 Advanced diagnostics Oncology and innovative therapies Advanced technologies and experimental models

Veeraraghavan, Vishnu P. MD, DS, PhD*; Minervini, Giuseppe MD, DS, PhD†,‡; Russo, Diana MD, DS, PhD‡; Cicciù, Marco MD, DS, PhD§; Ronsivalle, Vincenzo MD, DS, PhD§

TSRF-Dist: a novel time series distance based on extremely randomized canonical interval forests
2025 Spoke 2 Advanced diagnostics

Alberto Azzari, Manuele Bicego, Carlo Combi, Andrea Cracco & Pietro Sala

The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophages
2023 Spoke 1 Infectious diseases and Immunology Preclinical studies on fundamental disease mechanisms

Alessandra Romagnoli, Martina Di Rienzo, Elisa Petruccioli, Carmela Fusco, Ivana Palucci, Lucia Micale, Tommaso Mazza, Giovanni Delogu, Giuseppe Merla, Delia Goletti, Mauro Piacentini & Gian Maria Fimia

Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations
2024 Spoke 2 Preclinical studies on fundamental disease mechanisms

Patrizia Benzoni, Elisabetta Gazzerro, Chiara Fiorillo, Serena Baratto, Chiara Bartolucci, Stefano Severi, Raffaella Milanesi, Melania Lippi, Marianna Langione, Carmen Murano, Clarissa Meoni, Vera Popolizio, Alessandro Cospito, Mirko Baruscotti, Annalisa Bucchi and Andrea Barbuti

Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
2024 Spoke 1 Infectious diseases and Immunology Preclinical studies on fundamental disease mechanisms

Tonino Alonzi, Alessandra Aiello, Michela Sali, Giovanni Delogu, Valeria Rachela Villella, Valeria Raia, Emanuele Nicastri, Mauro Piacentini, Delia Goletti

Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
2024 Spoke 1 Infectious diseases and Immunology Preclinical studies on fundamental disease mechanisms

Saeid Najafi-Fard, Chiara Farroni, Linda Petrone, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, Gilda Cuzzi, Tonino Alonzi…

Thioredoxin-interacting protein (TXNIP) is a substrate of the NEDD4-like E3 ubiquitin-protein ligase WWP1 in cellular redox state regulation of acute myeloid leukemia cells
2024 Spoke 1 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Sara Giovannini, Yanan Li, Rosalba Pecorari, Claudia Fierro, Claudia Fiorilli, Federica Corigliano, Valeria Moriconi, Ji Zhou, Anna De Antoni, Artem Smirnov, Sara Rinalducci, Anna Maria Timperio, Massimiliano Agostini, Jinping Zhang, Yufang Shi, Eleonora Candi, Gerry Melino, Francesca Bernassola

Role of AMBRA1 in mitophagy regulation: emerging evidence in aging-related diseases
2024 Spoke 1 Preclinical studies on fundamental disease mechanisms

Martina Di Rienzo, Alessandra Romagnoli, Giulia Refolo, Tiziana Vescovo, Fabiola Ciccosanti, Candida Zuchegna…

Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives
2024 Spoke 1 Oncology and innovative therapies

Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi ,Riccardo Gili , Valentina Forte, Roberta Roncarati , Daria Maria Filippini and Manuela Ferracin

Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms
2024 Spoke 1 Oncology and innovative therapies

Chiara Carretta, Sandra Parenti, Matteo Bertesi, Sebastiano Rontauroli, Filippo Badii, Lara Tavernari, Elena Genovese, Marica Malerba, Elisa Papa, Samantha Sperduti, Elena Enzo, Margherita Mirabile, Francesca Pedrazzi, Anita Neroni, Camilla Tombari, Barbara Mora, Margherita Maffioli, Marco Mondini, Marco Brociner, Monica Maccaferri, Elena Tenedini, Silvia Martinelli, Niccolò Bartalucci, Elisa Bianchi, on behalf of MYNERVA (Myeloid NEoplasms Research Venture AIRC)

Exposure to serum from exclusive heated tobacco product smokers induces mTOR activation and fibrotic features in human cardiac stromal cells
2024 Spoke 1 Cardiovascular diseases

Vittorio Picchio, Francesca Pagano, Roberto Carnevale, Alessandra D’Amico, Claudia Cozzolino, Erica Floris, Antonella Bordin, Leonardo Schirone, Daniele Vecchio, Wael Saade, Fabio Miraldi, Elena De Falco, Sebastiano Sciarretta, Mariangela Peruzzi, Giuseppe Biondi-Zoccai, Giacomo Frati, Isotta Chimenti

A Migration Framework for Active BPMN Processes in Healthcare
2024 Spoke 2 Advanced diagnostics

Matteo Mantovani; Emanuele Chini; Carlo Combi

  1. «
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10
  12. »

Posts navigation

Older posts
Newer posts

Fondazione HEAL ITALIA
Sede Operativa: Via Isidoro La Lumia 19C, Palermo PA
Complesso Monumentale dello Steri,
Piazza Marina, 61, Palermo PA
info@healitalia.eu

Dona il tuo 5×1000 alla ricerca
Codice Fiscale Heal Italia: 97370050821

  • Home
  • Rassegna Stampa
  • Fondazione trasparente
  • Termini e condizioni di utilizzo
  • Procedura per i diritti degli interessati
  • Privacy policy
  • Cookie policy
  • Informativa email
  • Contatti
  • Partner
  • News
  • Chi siamo

Questo sito è stato sviluppato dalla Fondazione HEAL ITALIA nell’ambito del progetto finanziato dall’Unione europea – (NextGenerationEU) – PNRR Missione 4, Componente 2, Investimento 1.3.